Beiying Dai
Nanjing, 211112, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of novel small molecule inhibitor targeting the tumor promoting effect of transcription factor PLAGL2.
Journal: European journal of medicinal chemistry
Published: October 22, 2025
Discovery of Novel 2-Oxoacetamide Derivatives as B3GAT3 Inhibitors for the Treatment of Hepatocellular Carcinoma.
Journal: Journal of medicinal chemistry
Published: June 26, 2024
Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer.
Journal: European journal of pharmacology
Published: October 28, 2022
RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching.
Journal: Experimental dermatology
Published: April 16, 2022
PLAGL2-EGFR-HIF-1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity.
Journal: Hepatology (Baltimore, Md.)
Published: January 11, 2020
Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy.
Journal: Medicinal research reviews
Published: November 13, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026